Us Bancorp \De\ Shattuck Labs, Inc. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$2.7 - $4.59 $1,309 - $2,226	-485 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$4.22 - $8.89 $1,346 - $2,835	319 Added 192.17%	485 $2,000
Q4 2021 Feb 11, 2022	SELL	$8.36 - $21.08 $4,205 - $10,603	-503 Reduced 75.19%	166 $1,000
Q3 2021 Nov 10, 2021	BUY	$17.57 - $28.95 $11,754 - $19,367	669 New	669 $14,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $42.4M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.